Profile
Full Name
Summit Therapeutics Inc.Ticker
NASDAQ: SMMTExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
March 5, 2015Indexes
Not includedWebsite
http://www.smmttx.comEmployees
159Key Details
Price
$26.66(-0.30%)
Market cap
$19.80B(Large cap)
Last Dividend
-
TTM Dividend yield
-
Annual EPS
-$0.31(+68.69% YoY)
Next earnings date
Aug 6, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Summit Therapeutics Inc. doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Jul 1, 25 UBS
BuyJul 1, 25 HC Wainwright & Co.
BuyJun 11, 25 Leerink Partners
UnderperformJun 2, 25 JMP Securities
Market OutperformMay 2, 25 Goldman Sachs
BuyApr 28, 25 JMP Securities
Market OutperformApr 25, 25 Jefferies
BuyApr 23, 25 Cantor Fitzgerald
OverweightMar 26, 25 Citigroup
BuyMar 21, 25 Cantor Fitzgerald
OverweightInstitutional Ownership
- What is the ticker symbol for Summit Therapeutics Inc.?
- Does Summit Therapeutics Inc. pay dividends?
- What sector is Summit Therapeutics Inc. in?
- What industry is Summit Therapeutics Inc. in?
- What country is Summit Therapeutics Inc. based in?
- When did Summit Therapeutics Inc. go public?
- Is Summit Therapeutics Inc. in the S&P 500?
- Is Summit Therapeutics Inc. in the NASDAQ 100?
- Is Summit Therapeutics Inc. in the Dow Jones?
- When was Summit Therapeutics Inc.'s last earnings report?
- When does Summit Therapeutics Inc. report earnings?
What is the ticker symbol for Summit Therapeutics Inc.?
The ticker symbol for Summit Therapeutics Inc. is NASDAQ:SMMT
Does Summit Therapeutics Inc. pay dividends?
No, Summit Therapeutics Inc. does not pay dividends
What sector is Summit Therapeutics Inc. in?
Summit Therapeutics Inc. is in the Healthcare sector
What industry is Summit Therapeutics Inc. in?
Summit Therapeutics Inc. is in the Biotechnology industry
What country is Summit Therapeutics Inc. based in?
Summit Therapeutics Inc. is headquartered in United States
When did Summit Therapeutics Inc. go public?
Summit Therapeutics Inc.'s initial public offering (IPO) was on March 5, 2015
Is Summit Therapeutics Inc. in the S&P 500?
No, Summit Therapeutics Inc. is not included in the S&P 500 index
Is Summit Therapeutics Inc. in the NASDAQ 100?
No, Summit Therapeutics Inc. is not included in the NASDAQ 100 index
Is Summit Therapeutics Inc. in the Dow Jones?
No, Summit Therapeutics Inc. is not included in the Dow Jones index
When was Summit Therapeutics Inc.'s last earnings report?
Summit Therapeutics Inc.'s most recent earnings report was on May 1, 2025
When does Summit Therapeutics Inc. report earnings?
The next expected earnings date for Summit Therapeutics Inc. is August 6, 2025